Regenerative Medicine

Induced pluripotent stem cells (iPSCs) create patient-specific regenerative cells. 3D bioprinting constructs tissue structures layer by layer. Decellularized scaffolds provide natural tissue architecture for recellularization. Exosome therapy delivers regenerative signals without whole-cell transplantation. Gene editing repairs genetic defects in regenerative cell populations.

Stem cell therapy regenerates damaged cartilage in joints. Skin substitutes treat severe burns and chronic wounds. Gene therapy restores vision in inherited retinal disease. Bioprinted tissue models replace animal testing in drug development.

The global regenerative medicine market exceeded $30 billion in 2025, spanning cell therapy, tissue engineering, gene therapy, and biomaterials.